Caligan Partners LP's Form 4 filing
Standard Biotools Inc.LAB · filed May 2, 2022
- Accession no.
- 0000902664-22-002740
- Filed
- May 2, 2022, 7:44 PM ET
- Trade date
- Apr 28-May 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.08M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Caligan Partners LPCIK 0001727492 | 10% Owner |
| Johnson David EdwardCIK 0001785557 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2022 | Common Stock, $0.001 par value per share ("Common Stock") | PPurchaseAcquired | +27,600 | $2.40F1,F5 | +$66,240 | 9,112,438 | Indirect | |
| Apr 29, 2022 | Common Stock | PPurchaseAcquired | +247,400 | $2.66F3,F5 | +$658,084 | 9,359,838 | Indirect | |
| May 2, 2022 | Common Stock | PPurchaseAcquired | +125,000 | $2.81F4,F5 | +$351,250 | 9,484,838 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price is the volume weighted average selling price of all sales by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $2.37 to $2.44.
Referenced by the price of 1 transaction in Table I.
- F3
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $2.57 to $2.70.
Referenced by the price of 1 transaction in Table I.
- F4
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $ 2.71 to $2.89.
Referenced by the price of 1 transaction in Table I.
- F5
The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
Remarks
The Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.